Ginseng for Gesundheit? Latest Study on Colds
Benefits Reported in Study Funded by Ginseng Maker; Results Debated
Oct. 24, 2005 -- Does ginseng help prevent or treat the common cold?
Two different takes on that topic appear in the latest issue of the Canadian Medical Association Journal.
On one hand, the journal contains a study showing fewer, shorter colds in Canadians who took ginseng pills daily for four months during flu season.
However, the study's findings are questioned in a journal editorial.
The ginseng study was conducted by researchers including Tapan Basu, PhD, of the Agricultural, Food, and Nutritional Sciences department at Canada's University of Alberta. The study was funded by the ginseng pill's manufacturer.
Participants were adults aged 18-65 living in Edmonton, Alberta. They all reported having at least two colds during the previous year but were otherwise basically healthy.
Participants were given capsules of North American ginseng or dummy pills (placebo). The ginseng pills were standardized to have 200 milligrams of freeze-dried ginseng extract per capsule.
Participants were told to take two pills daily for four months during the flu season of 2003-2004 and to rate their cold symptoms on a four-point scale during that season.
The ginseng group reportedly had fewer, milder, shorter colds.
For instance, one in 10 people in the ginseng group reported having two or more colds that winter, compared with about 23% of those taking the placebo.
Colds lasted about 11 days for the ginseng group and 16.5 days for the placebo group, the study shows. There was no difference between the groups in the use of additional medications such as anti-inflammatory drugs or antibiotics, according to the researchers.
Participants weren't told which type of pill they had gotten. When asked by the researchers after the study, most people in both groups said they thought they had gotten the ginseng pills.
Both pills were generally well tolerated, write Basu and colleagues.
The study was funded by the ginseng pill's maker, CV Technologies of Edmonton, Alberta. The company didn't have any other role in the study, the journal states.
The study relied on participants' reports. It didn't sort out who had a common cold and who had the flu.